Awareness of isotretinoin use and Saudi FDA pregnancy prevention program in Riyadh, Saudi Arabia: A cross-sectional study among female patients

Awareness of isotretinoin use and Saudi FDA pregnancy prevention program in Riyadh, Saudi Arabia: A cross-sectional study among female patients

Introduction: Oral isotretinoin is an effective agent for the treatment of severe cystic acne. Isotretinoin is a teratogen; there is an increased risk of congenital defects in infants exposed to the drug in the uterus. The Saudi Food and Drug Authority (SFDA) has implemented a pregnancy prevention p...

Full description

Bibliographic Details
Main Authors: Alnada Abdalla Mohamed Ibrahim, Amal Almotiry Alshatri, Salem Alsuwaidan, Lulu Almutairi, Nasser Aljasser, Mansour Adam Mahmoud, Afnan Alaseeri, Abrar Almonysir, Badraa Alotaibi, Batoul Alrasheed, Maram Alfawaz
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Saudi Pharmaceutical Journal
Subjects:
Isotretinoin
Teratogenicity
Pregnancy prevention program
Awareness
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016421000700

Internet

http://www.sciencedirect.com/science/article/pii/S1319016421000700

Similar Items